Annual CFO
-$295.50 M
-$43.30 M-17.17%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual cash flow from operations is -$295.50 million, with the most recent change of -$43.30 million (-17.17%) on December 31, 2023.
- During the last 3 years, DNA annual CFO has fallen by -$159.67 million (-117.55%).
- DNA annual CFO is now -561.62% below its all-time high of -$44.66 million, reached on December 31, 2019.
Performance
DNA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$103.50 M
-$19.11 M-22.65%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly cash flow from operations is -$103.50 million, with the most recent change of -$19.11 million (-22.65%) on September 30, 2024.
- Over the past year, DNA quarterly CFO has dropped by -$45.67 million (-78.97%).
- DNA quarterly CFO is now -1877.10% below its all-time high of -$5.24 million, reached on September 30, 2021.
Performance
DNA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$334.98 M
-$29.95 M-9.82%
September 30, 2024
Summary
- As of February 8, 2025, DNA TTM cash flow from operations is -$334.98 million, with the most recent change of -$29.95 million (-9.82%) on September 30, 2024.
- Over the past year, DNA TTM CFO has dropped by -$39.48 million (-13.36%).
- DNA TTM CFO is now -595.98% below its all-time high of -$48.13 million, reached on March 31, 2021.
Performance
DNA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
DNA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.2% | -79.0% | -13.4% |
| 3 y3 years | -117.5% | -79.0% | -13.4% |
| 5 y5 years | -561.6% | - | - |
DNA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.2% | at low | -420.2% | +37.5% | -48.5% | +2.1% |
| 5 y | 5-year | -561.6% | at low | -1877.1% | +37.5% | -596.0% | +2.1% |
| alltime | all time | -561.6% | at low | -1877.1% | +37.5% | -596.0% | +2.1% |
Ginkgo Bioworks Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$103.50 M(+22.6%) | -$334.98 M(+9.8%) |
| Jun 2024 | - | -$84.39 M(-5.5%) | -$305.03 M(+3.7%) |
| Mar 2024 | - | -$89.26 M(+54.3%) | -$294.17 M(-0.4%) |
| Dec 2023 | -$295.50 M(+17.2%) | -$57.83 M(-21.4%) | -$295.50 M(-13.6%) |
| Sep 2023 | - | -$73.55 M(+0.0%) | -$342.20 M(+15.2%) |
| Jun 2023 | - | -$73.53 M(-18.8%) | -$297.01 M(-8.0%) |
| Mar 2023 | - | -$90.58 M(-13.3%) | -$322.88 M(+28.0%) |
| Dec 2022 | -$252.20 M | -$104.53 M(+268.6%) | -$252.20 M(-19.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$28.36 M(-71.5%) | -$313.21 M(+8.0%) |
| Jun 2022 | - | -$99.41 M(+399.6%) | -$290.08 M(+28.6%) |
| Mar 2022 | - | -$19.90 M(-88.0%) | -$225.59 M(-11.1%) |
| Dec 2021 | -$253.82 M(+86.9%) | -$165.54 M(+3062.2%) | -$253.82 M(+187.5%) |
| Sep 2021 | - | -$5.24 M(-85.0%) | -$88.28 M(+6.3%) |
| Jun 2021 | - | -$34.91 M(-27.5%) | -$83.04 M(+72.5%) |
| Mar 2021 | - | -$48.13 M | -$48.13 M |
| Dec 2020 | -$135.83 M(+204.1%) | - | - |
| Dec 2019 | -$44.66 M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual cash flow from operations?
- What is the all time high annual CFO for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual CFO year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly CFO year-on-year change?
- What is Ginkgo Bioworks Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM CFO year-on-year change?
What is Ginkgo Bioworks Holdings annual cash flow from operations?
The current annual CFO of DNA is -$295.50 M
What is the all time high annual CFO for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual cash flow from operations is -$44.66 M
What is Ginkgo Bioworks Holdings annual CFO year-on-year change?
Over the past year, DNA annual cash flow from operations has changed by -$43.30 M (-17.17%)
What is Ginkgo Bioworks Holdings quarterly cash flow from operations?
The current quarterly CFO of DNA is -$103.50 M
What is the all time high quarterly CFO for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly cash flow from operations is -$5.24 M
What is Ginkgo Bioworks Holdings quarterly CFO year-on-year change?
Over the past year, DNA quarterly cash flow from operations has changed by -$45.67 M (-78.97%)
What is Ginkgo Bioworks Holdings TTM cash flow from operations?
The current TTM CFO of DNA is -$334.98 M
What is the all time high TTM CFO for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM cash flow from operations is -$48.13 M
What is Ginkgo Bioworks Holdings TTM CFO year-on-year change?
Over the past year, DNA TTM cash flow from operations has changed by -$39.48 M (-13.36%)